NK cells (Natural Killer cells) are a special type of white blood cell that play an important role in the immune system, recognizing and attacking cancer cells and infected cells and contributing to the immune response. Because of these properties, NK cells have attracted attention in cancer treatment and infectious disease research, and treatments and research that utilise their activity are progressing.
Cancer immune cell therapy using human self-activated NK cells is a treatment method in which the patient's own NK lymphocytes are collected, cultured to increase their number, and then returned to the body through an intravenous drip. This is said to improve immunity and minimise the burden on the body since it uses your own cells.
NK cells are lymphocytes that are at the forefront of the immune system, finding and attacking cancer cells and infected cells, and have characteristics that make them susceptible to ageing and lifestyle factors.
NK cells play a role in innate immunity, recognizing and attacking abnormal cells such as cancer cells and virus-infected cells. NK cell therapy activates these innate immune responses and strengthens the patient's immune system.
Normally, in NK cell therapy, NK cells are obtained from the patient themselves, expanded, and then given back to the patient. This reduces individual differences in immune responses because the patient's own cells are used.
NK cell therapy, which is attracting attention especially in cancer treatment, is based on the ability of NK cells to attack cancer cells because they have more specific surface markings than normal cells.
It is also known as a minimally invasive treatment, as compared to some other immunotherapies, patients typically only obtain their own cells and have relatively few possible side effects.
NK cell therapy is also expected to prevent recurrence of cancer, etc. Cancer recurrence may be caused by residual cancer cells, so NK cells may recognize and attack these remaining cells. It may prevent recurrence.
First, we carefully listen to the patient's wishes and assess the patient's condition. The doctor will then explain the purpose, treatment details, safety, etc. of regenerative medicine.
After obtaining consent from the patient, we will draw blood and conduct tests. When blood is drawn, various tests are performed to check for infectious diseases such as viruses.
We will report the results of the preliminary inspection.
NK stem cultured for 4 weeks are administered via infusion. NK stem is administered intravenously over a period of approximately 1 hour. For local injections to the face, the injection will be given to the entire face.
